Callos Andrew sold CYTK
January 5, 2026 · Form 4 insider transaction
Callos Andrew sold 15,000 shares of Cytokinetics, Incorporated at $60.28 per share, a transaction worth $904.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
15,000
Price
$60.28
Total value
$904.2K
InsiderCallos Andrew
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 5, 2026
Filing dateJanuary 5, 2026
Shares owned after50,440
OwnershipDirect
10b5-1 planNo
AmendedNo